Skip to content
EUGOGO
  • Who we are
    • EUGOGO mission
    • Executive Committee
    • EUGOGO Working Groups
    • Past Executive Committee Members
    • Trustees and Honorary Members
    • Statutes and Policy for Conflicts of Interest
    • Affiliations
  • Where we are
  • What do we offer
    • EUGOGO Teaching Course
    • EUGOGO book
    • EUGOGO activities
    • Publications and Guidelines
    • Clinical assessment tools
    • Announcement of NON-EUGOGO events on GO
    • News
  • Members Area
  • Join Eugogo
  • Donation

admin

Asymmetry indicates worse disease in Graves’ Orbitopathy: results from a prospective cross-sectional multicentre study.

J Endocrinol Invest. 2020 Dec;43(12):1717-1722 P Perros, M Zarkovic et al. on behalf of the European Group on Graves’ Orbitopathy (EUGOGO).

The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy.

European Journal of Endocrinology. 2021;185(4):G43-G67. doi.org/10.1530/EJE-21-0479 L Bartalena, GJ Kahaly, L Baldeschi, CM Dayan, A Eckstein, C Marcocci, M Marinò, B Vaidya andWM Wiersinga on behalf of EUGOGO.

Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)

Br J Ophthalmology. 2023;epub ahead of print: doi:10.1136/bjo-2022-322442 A Schuh, A Goksun, L Baldeschi, CR Hintschich et al. on behalf of EUGOGO. 

Newer posts
← Previous Page1 … Page4 Page5

You are currently not logged in. Please login here.

Email address: secretary@eugogo.eu

2026 © All Rights Reserved.

Imprint / Legal Notice | Data Privacy | Cookie Policy